REGN
Regeneron Pharmaceuticals, Inc.
Healthcare
$642.59
as of May 21, 2026
Sign in to add REGN to your portfolio.
Sign inMarket cap
$66.94B
P/E (TTM)
15.3x
EPS (TTM)
$42.53
Dividend yield
0.56%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $16.07B | $8.08B | $6.53B | 83.1% | 55.7% | $76.40 |
| 2022 | $12.17B | $4.34B | $4.42B | 86.0% | 44.2% | $40.51 |
| 2023 | $13.12B | $3.95B | $3.67B | 82.9% | 33.2% | $37.05 |
| 2024 | $14.20B | $4.41B | $3.66B | 86.1% | 28.1% | $40.90 |
| 2025 | $14.34B | $4.50B | $4.08B | 85.4% | 24.9% | $43.07 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $645.00 | $642.59 | 1.18M |
| May 20, 2026 | $634.32 | $649.76 | 1.17M |
| May 19, 2026 | $630.49 | $630.30 | 1.45M |
| May 18, 2026 | $615.93 | $629.68 | 3.00M |
| May 15, 2026 | $712.69 | $698.25 | 728.23K |
| May 14, 2026 | $719.00 | $712.87 | 767.21K |
| May 13, 2026 | $721.29 | $719.88 | 879.37K |
| May 12, 2026 | $716.39 | $723.41 | 824.58K |
| May 11, 2026 | $714.99 | $712.77 | 1.23M |
| May 08, 2026 | $709.29 | $714.89 | 589.04K |
| May 07, 2026 | $718.50 | $709.10 | 774.68K |
| May 06, 2026 | $703.33 | $721.05 | 739.91K |
| May 05, 2026 | $710.73 | $702.27 | 642.80K |
| May 04, 2026 | $702.56 | $709.21 | 554.27K |
| May 01, 2026 | $703.02 | $701.42 | 729.18K |
| Apr 30, 2026 | $693.08 | $707.06 | 1.10M |
| Apr 29, 2026 | $705.11 | $686.36 | 1.83M |
| Apr 28, 2026 | $751.37 | $731.77 | 569.17K |
| Apr 27, 2026 | $745.47 | $744.44 | 603.28K |
| Apr 24, 2026 | $760.00 | $751.57 | 809.55K |
| Apr 23, 2026 | $750.99 | $766.02 | 928.72K |
| Apr 22, 2026 | $751.48 | $746.58 | 901.96K |
| Apr 21, 2026 | $746.20 | $747.36 | 707.47K |
| Apr 20, 2026 | $750.00 | $749.41 | 493.84K |
Profitability & balance
- ROE (TTM)
- 14.3%
- Gross margin
- 84.5%
- Operating margin
- 24.3%
- Net margin
- 29.6%
- Debt / equity
- 0.09